272 related articles for article (PubMed ID: 15665857)
21. Cloning and characterization of the monkey histamine H3 receptor isoforms.
Strakhova MI; Fox GB; Carr TL; Witte DG; Vortherms TA; Manelli AM; Miller TR; Yao BB; Brioni JD; Esbenshade TA
Eur J Pharmacol; 2008 Dec; 601(1-3):8-15. PubMed ID: 18977214
[TBL] [Abstract][Full Text] [Related]
22. Nasal allergic response mediated by histamine H3 receptors in murine allergic rhinitis.
Nakaya M; Fukushima Y; Takeuchi N; Kaga K
Laryngoscope; 2005 Oct; 115(10):1778-84. PubMed ID: 16222194
[TBL] [Abstract][Full Text] [Related]
23. 5-hydroxyindole-2-carboxylic acid amides: novel histamine-3 receptor inverse agonists for the treatment of obesity.
Pierson PD; Fettes A; Freichel C; Gatti-McArthur S; Hertel C; Huwyler J; Mohr P; Nakagawa T; Nettekoven M; Plancher JM; Raab S; Richter H; Roche O; Rodríguez Sarmiento RM; Schmitt M; Schuler F; Takahashi T; Taylor S; Ullmer C; Wiegand R
J Med Chem; 2009 Jul; 52(13):3855-68. PubMed ID: 19456097
[TBL] [Abstract][Full Text] [Related]
24. Therapeutic potential of histamine H3 receptor agonists and antagonists.
Leurs R; Blandina P; Tedford C; Timmerman H
Trends Pharmacol Sci; 1998 May; 19(5):177-83. PubMed ID: 9652190
[TBL] [Abstract][Full Text] [Related]
25. Histamine H3 receptor antagonists: from target identification to drug leads.
Bonaventure P; Letavic M; Dugovic C; Wilson S; Aluisio L; Pudiak C; Lord B; Mazur C; Kamme F; Nishino S; Carruthers N; Lovenberg T
Biochem Pharmacol; 2007 Apr; 73(8):1084-96. PubMed ID: 17129577
[TBL] [Abstract][Full Text] [Related]
26. Recent advances in histamine H3 receptor antagonists/inverse agonists.
Łazewska D; Kieć-Kononowicz K
Expert Opin Ther Pat; 2010 Sep; 20(9):1147-69. PubMed ID: 20716022
[TBL] [Abstract][Full Text] [Related]
27. Refinement of histamine H3 ligands pharmacophore model leads to a new class of potent and selective naphthalene inverse agonists.
Roche O; Nettekoven M; Vifian W; Sarmiento RM
Bioorg Med Chem Lett; 2008 Aug; 18(15):4377-9. PubMed ID: 18606542
[TBL] [Abstract][Full Text] [Related]
28. Antiobesity evaluation of histamine H3 receptor (H3R) antagonist analogs of A-331440 with improved safety and efficacy.
Hancock AA; Diehl MS; Fey TA; Bush EN; Faghih R; Miller TR; Krueger KM; Pratt JK; Cowart MD; Dickinson RW; Shapiro R; Knourek-Segel VE; Droz BA; McDowell CA; Krishna G; Brune ME; Esbenshade TA; Jacobson PB
Inflamm Res; 2005 Apr; 54 Suppl 1():S27-9. PubMed ID: 15928821
[No Abstract] [Full Text] [Related]
29. The human histamine H3 receptor couples to GIRK channels in Xenopus oocytes.
Sahlholm K; Nilsson J; Marcellino D; Fuxe K; Arhem P
Eur J Pharmacol; 2007 Jul; 567(3):206-10. PubMed ID: 17537431
[TBL] [Abstract][Full Text] [Related]
30. [The histamine H3 receptor: a new target for the treatment of arousal and cognitive disorders].
Arrang JM
Ann Pharm Fr; 2007 Jul; 65(4):275-84. PubMed ID: 17652997
[TBL] [Abstract][Full Text] [Related]
31. Constitutive activity of the histamine H3 receptor.
Arrang JM; Morisset S; Gbahou F
Trends Pharmacol Sci; 2007 Jul; 28(7):350-7. PubMed ID: 17573125
[TBL] [Abstract][Full Text] [Related]
32. Aplysamine-1 and related analogs as histamine H3 receptor antagonists.
Swanson DM; Wilson SJ; Boggs JD; Xiao W; Apodaca R; Barbier AJ; Lovenberg TW; Carruthers NI
Bioorg Med Chem Lett; 2006 Feb; 16(4):897-900. PubMed ID: 16300945
[TBL] [Abstract][Full Text] [Related]
33. The histamine H3 receptor antagonist clobenpropit enhances GABA release to protect against NMDA-induced excitotoxicity through the cAMP/protein kinase A pathway in cultured cortical neurons.
Dai H; Fu Q; Shen Y; Hu W; Zhang Z; Timmerman H; Leurs R; Chen Z
Eur J Pharmacol; 2007 Jun; 563(1-3):117-23. PubMed ID: 17350613
[TBL] [Abstract][Full Text] [Related]
34. N-substituted piperidinyl alkyl imidazoles: discovery of methimepip as a potent and selective histamine H3 receptor agonist.
Kitbunnadaj R; Hashimoto T; Poli E; Zuiderveld OP; Menozzi A; Hidaka R; de Esch IJ; Bakker RA; Menge WM; Yamatodani A; Coruzzi G; Timmerman H; Leurs R
J Med Chem; 2005 Mar; 48(6):2100-7. PubMed ID: 15771452
[TBL] [Abstract][Full Text] [Related]
35. Keynote review: histamine H3 receptor antagonists reach out for the clinic.
Celanire S; Wijtmans M; Talaga P; Leurs R; de Esch IJ
Drug Discov Today; 2005 Dec; 10(23-24):1613-27. PubMed ID: 16376822
[TBL] [Abstract][Full Text] [Related]
36. Several down, a few to go: histamine H3 receptor ligands making the final push towards the market?
Kuhne S; Wijtmans M; Lim HD; Leurs R; de Esch IJ
Expert Opin Investig Drugs; 2011 Dec; 20(12):1629-48. PubMed ID: 21992603
[TBL] [Abstract][Full Text] [Related]
37. 4-benzyl-1H-imidazoles with oxazoline termini as histamine H3 receptor agonists.
Wijtmans M; Celanire S; Snip E; Gillard MR; Gelens E; Collart PP; Venhuis BJ; Christophe B; Hulscher S; van der Goot H; Lebon F; Timmerman H; Bakker RA; Lallemand BI; Leurs R; Talaga PE; de Esch IJ
J Med Chem; 2008 May; 51(10):2944-53. PubMed ID: 18433114
[TBL] [Abstract][Full Text] [Related]
38. Histamine H3-receptor isoforms.
Bakker RA
Inflamm Res; 2004 Oct; 53(10):509-16. PubMed ID: 15597144
[TBL] [Abstract][Full Text] [Related]
39. 2-(4-alkylpiperazin-1-yl)quinolines as a new class of imidazole-free histamine H3 receptor antagonists.
Zaragoza F; Stephensen H; Peschke B; Rimvall K
J Med Chem; 2005 Jan; 48(1):306-11. PubMed ID: 15634025
[TBL] [Abstract][Full Text] [Related]
40. Discovery of histamine H3 antagonists for the treatment of cognitive disorders and Alzheimer's disease.
Brioni JD; Esbenshade TA; Garrison TR; Bitner SR; Cowart MD
J Pharmacol Exp Ther; 2011 Jan; 336(1):38-46. PubMed ID: 20864505
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
